Based on key financial metrics such as the price-to-sales ratio, shareholder yield and the price-earnings ratio, the following 5 stocks made the list for top value stocks in the Healthcare Facilities & Services industry. Those looking for value stocks to add to their portfolio may want to use this list as a starting point for further investment research.
Why Focus on Undervalued Healthcare Facilities & Services Stocks?
Value investors seek to buy stocks at a discount to their intrinsic value. Long-term returns show that such strategies are advantageous. Value stocks, as a group, tend to outperform growth stocks over extended periods of time. Typically, value investors perform financial analysis of numerous metrics, don’t follow the herd and are long-term investors.
AAII’s A+ Investor Value Grade is derived from a stock’s Value Score. The Value Score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio, price-earnings ratio, enterprise-value-to-EBITDA (EV/EBITDA) ratio, shareholder yield, price-to-book-value ratio and price-to-free-cash-flow ratio. The score is variable, meaning it can consider all six ratios or, should any of the six ratios not be valid, the remaining ratios that are valid. To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios.
What Goes Into AAII’s Value Grade?
Stock evaluation requires access to huge amounts of data as well as the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movement. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors with that task.
AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A–F grades for more than just value. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others. Some stocks may even have null values for certain metrics like the price-earnings ratio or the price-to-book ratio but not others. An example of this would be a company with losses instead of profits or a negative book value because of heavy borrowing. Negative earnings or book value result in non-meaningful ratios that are left blank or null.
Click the button below to learn more about A+ Investor and subscribe today.
5 Undervalued Healthcare Facilities & Services Stocks
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued stocks in the Healthcare Facilities & Services industry for Tuesday, July 16, 2024. Let’s take a closer look at their individual scores to see how they measure up against each other and the Healthcare Facilities & Services industry median.
| Company | Ticker | Price/Sales | Price/Earnings | EV/EBITDA | Shareholder Yield | Price/Book Value | Price/Free Cash Flow | Value Grade |
| Ethema Health Corp | GRST | 0.70 | 4.3 | na | 0.0% | na | na | A |
| Pediatrix Medical Group Inc | MD | 0.29 | na | 8.1 | (1.2%) | 0.68 | 7.0 | A |
| ModivCare Inc | MODV | 0.13 | na | 10.7 | (0.3%) | 2.58 | na | B |
| OPKO Health Inc | OPK | 1.26 | na | na | 5.9% | 0.81 | na | A |
| Teladoc Health Inc | TDOC | 0.59 | na | 21.1 | (3.0%) | 0.68 | 4.6 | B |
The Value Grade is assigned based on how each stock’s composite valuation compares to all other stocks.
The process for assigning grades starts with each variable for a given stock. The percentile rankings for all valid ratios that a stock has are calculated. So, for instance, a stock could have a price-to-book ranking in the 43rd percentile, a price-earnings ranking in the 67th percentile, a price-to-sales ranking in the 23rd percentile, etc. Then, those rankings are averaged for each stock. (A minimum of two valid variables are required, though all six will be used if available.)
Once the average of the individual variables is calculated, that average is ranked against all stocks. Put another way, each stock’s composite valuation is compared to all other stocks. These ranks are then sorted into quintiles from the cheapest 20% (a grade of A) to the most expensive 20% (a grade of F).
As always, we recommend that you conduct proper due diligence and research before investing in any security. We also suggest that investors utilize numerous grades, not just value, when it comes to deciding whether a company is a good fit for their allocation needs.
Ethema Health Corp’s Value Grade
Value Grade:
| Metric | Score | GRST | Industry Median |
| Price/Sales | 25 | 0.70 | 1.22 |
| Price/Earnings | 4 | 4.3 | 22.8 |
| EV/EBITDA | na | na | 13.4 |
| Shareholder Yield | 48 | 0.0% | (1.7%) |
| Price/Book Value | na | na | 2.27 |
| Price/Free Cash Flow | na | na | 24.9 |
Ethema Health Corporation, together with its subsidiaries, operates in the behavioral healthcare space specifically in the treatment of substance-use disorders. The Company offers rehabilitation services in West Palm Beach, Florida. By working with scientists, doctors and researchers, the Company strives to develop better assessment and treatment modalities for the industry. The Company focuses on developing programs and techniques for North America.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
Ethema Health Corp has a Value Score of 89, which is considered to be undervalued.
When you look at Ethema Health Corp’s price-to-sales ratio at 0.70 compared to the industry median at 1.22, this company has a lower price relative to revenue compared to its peers. This could make Ethema Health Corp’s stock more attractive for value investors.
Ethema Health Corp’s price-earnings ratio is 4.35 compared to the industry median at 22.81. This means it has a lower share price relative to earnings compared to its peers. This could make Ethema Health Corp more attractive for value investors.
Shareholder yield is the sum of a stock’s dividend yield (paid over previous 12 months minus special dividends) and the percentage of net share buybacks over the previous 12 months. Ethema Health Corp’s shareholder yield is higher than its industry median ratio of (1.66%). Value investors may look for an attractive shareholder yield because it can be a powerful tool for identifying if the company has a good management team.
Pediatrix Medical Group Inc’s Value Grade
Value Grade:
| Metric | Score | MD | Industry Median |
| Price/Sales | 11 | 0.29 | 1.22 |
| Price/Earnings | na | na | 22.8 |
| EV/EBITDA | 35 | 8.1 | 13.4 |
| Shareholder Yield | 59 | (1.2%) | (1.7%) |
| Price/Book Value | 15 | 0.68 | 2.27 |
| Price/Free Cash Flow | 16 | 7.0 | 24.9 |
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
Pediatrix Medical Group Inc has a Value Score of 88, which is considered to be undervalued.
Pediatrix Medical Group Inc’s price-to-book ratio is higher than its peers. This could make Pediatrix Medical Group Inc less attractive for value investors when compared to the industry median at 2.27.
You can read more about Pediatrix Medical Group Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
ModivCare Inc’s Value Grade
Value Grade:
| Metric | Score | MODV | Industry Median |
| Price/Sales | 5 | 0.13 | 1.22 |
| Price/Earnings | na | na | 22.8 |
| EV/EBITDA | 49 | 10.7 | 13.4 |
| Shareholder Yield | 51 | (0.3%) | (1.7%) |
| Price/Book Value | 64 | 2.58 | 2.27 |
| Price/Free Cash Flow | na | na | 24.9 |
Modivcare Inc. is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for public and private payors and their members. It is a provider of non-emergency medical transportation (NEMT), personal care services (PCS), and remote patient monitoring (RPM) solutions. Its segments include NEMT, PCS, RPM, and Corporate and Other. The NEMT segment provides non-emergency medical transportation services throughout the country. The PCS segment provides non-medical personal care and home health services. Additionally, services provided in its PCS segment include placements of non-medical personal care assistants, home health aides and nurses primarily to Medicaid patient populations in need of care monitoring and assistance performing daily living activities in the home setting. RPM segment provides remote patient monitoring solutions, which include the monitoring of personal emergency response systems (PERS), vitals monitoring, and others.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
ModivCare Inc has a Value Score of 61, which is considered to be undervalued.
ModivCare Inc’s price-to-book ratio is lower than its peers. This could make ModivCare Inc more attractive for value investors when compared to the industry median at 2.27.
You can read more about ModivCare Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
OPKO Health Inc’s Value Grade
Value Grade:
| Metric | Score | OPK | Industry Median |
| Price/Sales | 40 | 1.26 | 1.22 |
| Price/Earnings | na | na | 22.8 |
| EV/EBITDA | na | na | 13.4 |
| Shareholder Yield | 14 | 5.9% | (1.7%) |
| Price/Book Value | 21 | 0.81 | 2.27 |
| Price/Free Cash Flow | na | na | 24.9 |
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company's diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. Its pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates specialized laboratory divisions, such as GenPath (Urology), GenPath (Oncology), and GenPath (Women's Health). It has two commercial stage pharmaceutical products and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Rayaldee, Rayaldee, Oxyntomodulin, Biologics, NGENLA Somatrogon, and Factor VIIa-CTP. It develops and manufactures specialty active pharmaceutical ingredients (APIs) through FineTech Pharmaceutical, Ltd.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
OPKO Health Inc has a Value Score of 90, which is considered to be undervalued.
OPKO Health Inc’s price-to-book ratio is higher than its peers. This could make OPKO Health Inc less attractive for value investors when compared to the industry median at 2.27.
You can read more about OPKO Health Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
Teladoc Health Inc’s Value Grade
Value Grade:
| Metric | Score | TDOC | Industry Median |
| Price/Sales | 22 | 0.59 | 1.22 |
| Price/Earnings | na | na | 22.8 |
| EV/EBITDA | 81 | 21.1 | 13.4 |
| Shareholder Yield | 68 | (3.0%) | (1.7%) |
| Price/Book Value | 15 | 0.68 | 2.27 |
| Price/Free Cash Flow | 9 | 4.6 | 24.9 |
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
Stocks with a Value Score from 81 to 100 are considered deep value, those with a score between 61 and 80 are value and so on.
Teladoc Health Inc has a Value Score of 66, which is considered to be undervalued.
Teladoc Health Inc’s price-to-book ratio is higher than its peers. This could make Teladoc Health Inc less attractive for value investors when compared to the industry median at 2.27.
You can read more about Teladoc Health Inc’s key financial metrics like shareholder yield, price-to-free-cash-flow and EV/EBITDA ratio, or learn more about its Momentum and Growth Grades, by subscribing to A+ Investor.
Other Healthcare Facilities & Services Stock Grades
Value is just one of the five Stock Grades included in our A+ Investor service. AAII members can see the top-graded stocks—those with grades of A or B for value, growth, momentum, earnings estimate revisions and quality—on the A+ Stock Grades Screener.
Also, if you want full access to all of AAII’s premium services, you can subscribe to one convenient bundled plan called AAII Platinum where you can try out A+ Investor, AAII Dividend Investing, the Stock Superstars Report, Growth Investing and VMQ Stocks. With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about Healthcare Facilities & Services stocks as well as other industrys.
Choosing Which of the 5 Best Healthcare Facilities & Services Stocks Is Right for You
Choosing which value stocks to invest in will ultimately depend on your individual goals and allocation; however, comparing similar value stocks in the same industry can help you analyze which might be better investments for you in the long run. So, let’s take a look at the Value Grade for all of our stocks.
- Ethema Health Corp stock has a Value Grade of A.
- Pediatrix Medical Group Inc stock has a Value Grade of A.
- ModivCare Inc stock has a Value Grade of B.
- OPKO Health Inc stock has a Value Grade of A.
- Teladoc Health Inc stock has a Value Grade of B.
Now that you have a bit more background about each of the 5 undervalued stocks in the Healthcare Facilities & Services industry as well as their overall grades, it’s time for you to conduct additional research to see if these could fit your portfolio needs based on your goals and risk tolerance. AAII can help you figure out both and identify which investments align with what works best for you.
We do so through a program of education that teaches you to invest for yourself and become an effective manager of your own wealth—no more relying on others for your financial independence. You can rely on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis that makes you a better investor.
A+ Investor adds to that qualitative teaching by giving you a powerful data suite that helps you whittle down investment decisions to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.
Additional Resources About Healthcare Facilities & Services Stocks
Want to learn more about Healthcare Facilities & Services stocks to see if they could be the right investment for you? Check out some additional resources and articles to help you on your financial journey.
- 5 Undervalued Healthcare Facilities & Services Stocks for Tuesday, July 16
- 3 Undervalued Healthcare Facilities & Services Stocks for Monday, July 15
- Why Auna SA’s (AUNA) Stock Is Up 4.87%
- Why Pediatrix Medical Group Inc’s
(MD) Stock Is Down 5.41%
AAII Disclaimer
We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith and we accept no liability for any errors or omissions. The full disclaimer can be read here.
Included With AAII Platinum
Screen: 23.7%
Annual Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.